Avatis Pharmaceuticals (OPC) Private Limited
About Avatis Pharmaceuticals (OPC) Private Limited
Data last updated:
Avatis Pharmaceuticals (OPC) Private Limited is a one person company based in Mumbai, Maharashtra, India. It operates in the diversified operations segment of the manufacturing sector. It was incorporated on 09 August 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U36900MH2018OPC312653. Its GSTIN is 27AARCA1921A1Z1 (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by director Avinash Shankarrao Ganjude.
Its last annual general meeting (AGM) was held on 20 September 2024, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹5.83 Lakh, a growth of 43% compared to the previous year. For the same year it recorded a net profit of ₹30,748 (net margin 5.3%) and EBITDA of ₹41,552 (EBITDA margin 7.1%). Revenue has grown at a compounded annual rate (CAGR) of 42% over three years and 27% over five years.
Company details
Contact details
Avatis Pharmaceuticals (OPC) Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered AddressE – 309 Crystal Plaza Premises Co – Op Soc Ltd 3rd Floor, Room – A Link Road Opp Infinity Mall Andheri West, Mumbai, Maharashtra, India – 400053
- IndustryManufacturing, Other, Manufacturing
To see the full contact details of Avatis Pharmaceuticals (OPC) Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Avatis Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Avatis Pharmaceuticals (OPC) Private Limited, buy the company report.
Financials of Avatis Pharmaceuticals (OPC) Private Limited
FY 2025 filings availableAvatis Pharmaceuticals (OPC) Private Limited reported revenue of ₹5.83 Lakh (up 43% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 27% over five years, including 43% growth in the latest year. EBITDA rose 53% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹41,552 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹30,748 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 7.1% | ||||
| Net Profit Margin | 5.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Avatis Pharmaceuticals (OPC) Private Limited, buy the company report.
Board of directors of Avatis Pharmaceuticals (OPC) Private Limited
Avatis Pharmaceuticals has 1 director on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Avinash Shankarrao Ganjude | Director | 09 Aug 2018 | 8 Years 2 Months | Current |
Peer comparison
Avatis Pharmaceuticals (OPC) Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Gyrus Pharmaceuticals Private Limited | ₹5.85 Lakh (FY 2025) | 21.0% | Amritsar, Punjab, India | |||
| Maclaren Pharmaceuticals Private Limited | ₹5.84 Lakh (FY 2022) | -16.0% | Bareilly, Uttar Pradesh, India | |||
| Avatis Pharmaceuticals (OPC) Private Limitedthis company | ₹5.83 Lakh (FY 2025) | ₹30,748 | 5.3% | 43.0% | Mumbai, Maharashtra, India | |
| Ceflact Pharmaceuticals Private Limited | ₹5.82 Lakh (FY 2024) | 19.0% | Allahabad, Uttar Pradesh, India | |||
| Sree Rakhadi Bio Pharmaceuticals Private Limited | ₹5.77 Lakh (FY 2019) | -23.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Avatis Pharmaceuticals (OPC) Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Avatis Pharmaceuticals (OPC) Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Avatis Pharmaceuticals (OPC) Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Avatis Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AARCA1921A1Z1 | Maharashtra | Active | 13 Oct 2018 |
To see the full GST registrations and return filing status of Avatis Pharmaceuticals (OPC) Private Limited, buy the company report.
Recent activity
Avatis Pharmaceuticals (OPC) Private Limited has 1 board change on record since 2018: 1 appointment. The latest: Avinash Shankarrao Ganjude was appointed as Director on 09 Aug 2018.
Frequently asked questions
Avatis Pharmaceuticals is an active company based in Mumbai, Maharashtra, India. The company works in other, within the manufacturing industry. It was incorporated on 09 August 2018 (8+ years old) and is registered under CIN U36900MH2018OPC312653.
Avatis Pharmaceuticals has 1 current director:
- Avinash Shankarrao Ganjude - Director
The latest financial statements of Avatis Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 20 September 2024. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Avatis Pharmaceuticals is 27AARCA1921A1Z1, registered in Maharashtra.
The CIN (Corporate Identification Number) of Avatis Pharmaceuticals is U36900MH2018OPC312653. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Avatis Pharmaceuticals was incorporated on 09 August 2018, making it 8+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Avatis Pharmaceuticals by revenue are Gyrus Pharmaceuticals Private Limited, Maclaren Pharmaceuticals Private Limited, Ceflact Pharmaceuticals Private Limited, Sree Rakhadi Bio Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Avinash Shankarrao Ganjude was appointed as Director on 09 Aug 2018.
The registered office of Avatis Pharmaceuticals is at E – 309 Crystal Plaza Premises Co – Op Soc Ltd 3rd Floor, Room – A Link Road Opp Infinity Mall Andheri West, Mumbai, Maharashtra, India – 400053.
Avatis Pharmaceuticals operates in the manufacturing industry, in the other segment.
Avatis Pharmaceuticals can be reached at its registered office: E – 309 Crystal Plaza Premises Co – Op Soc Ltd 3rd Floor, Room – A Link Road Opp Infinity Mall Andheri West, Mumbai, Maharashtra, India – 400053.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
